Found 130 bookmarks
Custom sorting
Parallel electrophysiological abnormalities due to COVID‐19 infection and to Alzheimer's disease and related dementia
Parallel electrophysiological abnormalities due to COVID‐19 infection and to Alzheimer's disease and related dementia
“Resting-state EEG abnormalities include EEG slowing (reduced alpha rhythm; increased slow waves) and epileptiform activity. An expert panel conducted a systematic review to present compelling evidence that cognitive deficits due to COVID-19 and to Alzheimer's disease and related dementia (ADRD) are driven by overlapping pathologies and neurophysiological abnormalities. EEG abnormalities seen in COVID-19 patients resemble those observed in early stages of neurodegenerative diseases, particularly ADRD”
·alz-journals.onlinelibrary.wiley.com·
Parallel electrophysiological abnormalities due to COVID‐19 infection and to Alzheimer's disease and related dementia
Cognitive dysfunction after covid-19
Cognitive dysfunction after covid-19
Cognitive problems are common after acute SARS-CoV-2 infection and can be disabling and frightening Symptoms tend to improve, but this may take up to a year. Those with chronically persistent symptoms lasting more than 12 months have a lower chance of improving Symptoms usually fluctuate Assessment should be directed to documenting the nature and trajectory of the impairment and excluding alternative diagnoses Self-management techniques may help patients manage their condition As of March 2023, when the Office for National Statistics stopped collecting data on this condition, 1.879 million individuals had self-assessed as having long covid—symptoms lasting more than 12 weeks following acute covid-19 infection. Of these, the proportion of individuals with symptoms lasting two years or more is around 42%, suggesting a decline in new cases of long covid but a persistence of those with ongoing symptoms.1 Some systematic reviews and meta-analyses have reported that up to a third of such individuals have persistent symptoms of cognitive impairment,23 but estimates vary widely and are complicated by methodological heterogeneity—eg, study size, assessment approach, follow-up duration, and different sampling frames (from self-reported surveys4 to large retrospective matched cohort studies of health records5), as discussed in a recent meta-analysis.6 The pathological underpinnings and potential therapeutic possibilities for cognitive impairment in long covid are also uncertain. The bulk of evidence to date is mechanistic (using basic science, animal models, or human tissue), observational (using longitudinal cohort studies), or hypothetical (reasoning from basic principles); this literature has been well summarised by the RECOVER Consortium.7 Because of the methodological heterogeneity, even when individual studies have been rigorously conducted, it is difficult to know to what extent their findings can be extrapolated and generalised across those with long covid. A few randomised controlled trials of potential treatments (pharmacological and non-pharmacological) have been completed, and others are under way.7 Cognitive performance is typically conceptualised in terms of functional domains depending upon the task at hand. Domains are hierarchical and inter-related, ranging from more basic sensory and perceptual processes to executive functioning and cognitive control.8 Both psychometric studies and qualitative studies of the patient experience identify problems across one or more of these domains. The most frequent symptoms seem to affect memory, attention, and concentration9 but discrete impairments are also seen in attentional and executive processing,1011 different types of memory,1012 visuospatial processing,13 and language.12 Many patients show deficits in multiple domains,1214 which may or may not correlate with self-reported symptoms.15 Moreover, linked systemic symptoms such as fatigue, insomnia, and a general befuddled state frequently termed “brain fog” are commonly reported. This seems to wax and wane with physical fatigue.16 A higher symptom burden is often associated with concomitant mood disorders or post-traumatic stress disorder, regardless of illness severity.15171819 Longitudinal cohort, case control, and qualitative studies have shown that while many individuals improve gradually over time, cognitive symptoms fluctuate unpredictably, causing uncertainty and (in some) anxiety.9202122 These impairments can have profound impacts on an individual’s life, with significant ramifications for relationships, jobs, and normal daily activities.422 This article explores the impact of these symptoms and offers a practical guide for GPs to help them approach cognitive dysfunction in individuals with long covid as indicated by the evolving and conflicting evidence base. An account from a patient’s perspective is given in box 1. Box 1 Patient experience When I got covid in December 2020 I was worried about what might happen. It was before vaccines, and the news was full of statistics of the hospitalised and those who’d lost their lives. After my 14 day isolation I was relieved to get back to normal life, thinking I had dodged quite a bullet. I was quickly aware that something wasn’t right. At the time of my infection I was a drama teacher in a secondary school. I remember being at work in January 2021 and finding it impossible to concentrate on what I had to do. Trying to focus made my head spin, and working on a computer screen was almost impossible. In the classroom I couldn’t process what was happening around me like I used to be able to, there was a sharpness lost, and that had a significant impact on both my teaching ability and classroom management. After several attempts at returning to work it became clear that I wasn’t able to continue, and I left teaching in January 2022. Alongside my difficulties focusing there are problems with memory. Remembering things from one minute to the next is often diff
·bmj.com·
Cognitive dysfunction after covid-19
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
Covid can disrupt the blood brain barrier, the shield that protects the nervous system making it ‘leaky’.
·nature.com·
Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment
A groundbreaking study aims to determine if long COVID-19 could lead to another type of dementia
A groundbreaking study aims to determine if long COVID-19 could lead to another type of dementia

“‘…there is evidence of fragments or an inflammatory kind of a massive inflammatory response that occurs triggered by COVID. And those inflammatory markers we tend to notice in the brain.’

And that could cause something called COVID-19 Cognitive Impairment.

‘And we are going to compare people with COVID cognitive impairment. To be clear on this, I think that COVID can cause cognitive impairment and maybe even dementia…’”

·kjzz.org·
A groundbreaking study aims to determine if long COVID-19 could lead to another type of dementia
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) - PubMed
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) - PubMed
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2
·pubmed.ncbi.nlm.nih.gov·
Prevalence and co-occurrence of cognitive impairment in children and young people up to 12-months post infection with SARS-CoV-2 (Omicron variant) - PubMed
COVID-related loss of smell tied to changes in the brain | CIDRAP
COVID-related loss of smell tied to changes in the brain | CIDRAP
“On MRI conducted during the game, loss of smell was associated with decreased functional activity during decision-making, loss of white-matter integrity, and thinning of the outer layer of the cerebrum in the parietal regions (responsible for processing sensory input, understanding spatial relationships, and how to navigate).”
·cidrap.umn.edu·
COVID-related loss of smell tied to changes in the brain | CIDRAP
Brain effects of mild COVID-19 in healthy young adults: A pilot study
Brain effects of mild COVID-19 in healthy young adults: A pilot study
“Our pilot data suggests that mild COVID-19 may result in brain pathology and impact neurocognitive function in younger adults in a manner parallel to prior findings in older individuals. Though findings may not generalize to other SARS-CoV-2 variants, larger longitudinal studies of mild COVID-19 should be undertaken to understand the potential clinical implications of these findings over the longer term.”
Our pilot data suggests that mild COVID-19 may result in brain pathology and impact neurocognitive function in younger adults in a manner parallel to prior findings in older individuals. Though findings may not generalize to other SARS-CoV-2 variants, larger longitudinal studies of mild COVID-19 should be undertaken to understand the potential clinical implications of these findings over the longer term.
·cell.com·
Brain effects of mild COVID-19 in healthy young adults: A pilot study
Study uncovers the basis of COVID-19-related brain fog | University of Minnesota
Study uncovers the basis of COVID-19-related brain fog | University of Minnesota

EXTREME and incomplete oversimplification of the many complex neurological issues caused by SarsCov2, but important facet of the vaguely defined “brain fog” of Long Covid and post-acute Covid lingering symptoms.

“Neurological symptoms have been widely observed in COVID-19 patients, with many survivors exhibiting persistent neurological and cognitive impairment. New research from the University of Minnesota found that COVID-19 triggers inflammation in the brain, which is linked to many COVID-related symptoms such as fatigue and ‘brain fog.’”

·twin-cities.umn.edu·
Study uncovers the basis of COVID-19-related brain fog | University of Minnesota
Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations
Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations
: “Patients who presented with anosmia exhibited more IMPULSIVE alternative changes…Anosmia correlated with brain measures, including decreased functional activity during the decision-making task, thinning of cortical thickness in parietal regions, and loss of white matter integrity.”
·nature.com·
Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations
Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations
Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations
“Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations”
·x.com·
Patients recovering from COVID-19 who presented with anosmia during their acute episode have behavioral, functional, and structural brain alterations
Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI
Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI
Study examining patients at a long COVID neurology clinic showing deficits in executive, attention, language and memory functions. MRIs showed reduced blood flow to frontal, parietal and temporal regions of the brain compared to age & sex matched controls
·nature.com·
Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI
Tatiana Prowell, MD on Twitter
Tatiana Prowell, MD on Twitter
A study from #Brazil finds 1 in 4 adults who had mild #COVID19 demonstrated cognitive deficits. The average age of study participants was 38. See what happened when they were asked to copy a diagram. We are not prepared for this.
·twitter.com·
Tatiana Prowell, MD on Twitter
The effects of COVID-19 on cognitive performance in a community-based cohort: A COVID Symptom Study Biobank observational study
The effects of COVID-19 on cognitive performance in a community-based cohort: A COVID Symptom Study Biobank observational study
"Cognitive deficits following SARS-CoV-2 infection were detectable nearly two years post infection, and largest for individuals with longer symptom durations, ongoing symptoms, and/or more severe infection."
·medrxiv.org·
The effects of COVID-19 on cognitive performance in a community-based cohort: A COVID Symptom Study Biobank observational study
Symptomatic COVID-19 is associated with deficits in task-related cognitive function and psychiatric symptoms
Symptomatic COVID-19 is associated with deficits in task-related cognitive function and psychiatric symptoms
"The results indicated that symptomatic COVID-19 was associated with the lower performance of cognitive tasks involving decision-making and executive function, with low scores in delay discounting and Flanker test scores, respectively."
·news-medical.net·
Symptomatic COVID-19 is associated with deficits in task-related cognitive function and psychiatric symptoms
Long COVID Linked to Lower Brain Oxygen Levels, Cognitive Problems and Psychiatric Symptoms - Neuroscience News
Long COVID Linked to Lower Brain Oxygen Levels, Cognitive Problems and Psychiatric Symptoms - Neuroscience News
"Long COVID is linked to reduced oxygen uptake in the brain, a new study reports...finding is significant as a lack of sufficient oxygen supply may be one of the mechanisms that cause brain fog, cognitive problems...depression and anxiety"
·neurosciencenews.com·
Long COVID Linked to Lower Brain Oxygen Levels, Cognitive Problems and Psychiatric Symptoms - Neuroscience News
What we now know about long COVID and our brains
What we now know about long COVID and our brains
"Of more than 665 million cases worldwide, nearly 1 in every 2 people with COVID-19 is at risk of developing Post-COVID-19 Neurological Syndrome (PCNS).. PCNS mimic some of the symptoms after a stroke and younger adults seem to be at particular risk."
·pursuit.unimelb.edu.au·
What we now know about long COVID and our brains